DA
Deepak Anandarao Wadkar
About Deepak Anandarao Wadkar
Data last updated:
Deepak Anandarao Wadkar is a Director at Cross Berry Pharmaceuticals Private Limited (since 2019). The companies operate in Chemicals and Jewelry & Fashion Accessories. Cross Berry Pharmaceuticals Private Limited reported revenue of ₹69.6 Lakh (FY 2020). Earlier, Deepak Anandarao Wadkar was a Director at Zwd India Private Limited (2017–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2019 | 2014 | ₹69.6 Lakh (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Nov 2017 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepak Anandarao Wadkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashalata Deepak Wadakar | 09080919 | Cross Berry Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Anandarao Wadkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Anandarao Wadkar
Deepak Anandarao Wadkar currently holds 1 directorship: Cross Berry Pharmaceuticals Private Limited (Director, since 26 Jul 2019, revenue βΉ69.6 Lakh (FY 2020)).
Deepak Anandarao Wadkar was first appointed on 20 Nov 2017 as Director at Zwd India Private Limited. The most recent appointment on record is 26 Jul 2019 at Cross Berry Pharmaceuticals Private Limited.
Deepak Anandarao Wadkar held 1 earlier board appointment: Zwd India Private Limited (Director, 20 Nov 2017 to 24 Sep 2021).
The current boards of Deepak Anandarao Wadkar's companies include Ashalata Deepak Wadakar (Cross Berry Pharmaceuticals Private Limited).